Disposition of homocysteine in rat hepatocytes and in nontransformed and malignant mouse embryo fibroblasts following exposure to inhibitors of S-adenosylhomocysteine catabolism.
S-Adenosylhomocysteine (AdoHcy) is catabolized to adenosine and homocysteine through the action of AdoHcy hydrolase, and this reaction is the only known source of L-homocysteine in vertebrates. The disposition of endogenously formed L-homocysteine was investigated in isolated rat hepatocytes and nontransformed and malignant C3H/10T1/2 mouse embryo fibroblasts exposed to 3-deazaaristeromycin or D-eritadenine, compounds which are potent inhibitors of AdoHcy hydrolase. Cells in suspension release large amounts of L-homocysteine into the extracellular medium whereas small amounts are retained within the intracellular compartment. The L-homocysteine egress is inhibited by 3-deazaaristeromycin or D-eritadenine in a manner which closely parallels the inhibitory effect on AdoHcy catabolism, suggesting that L-homocysteine egress may be coupled to its formation from AdoHcy. In liver cells, the accumulation of AdoHcy exceeded the inhibition of L-homocysteine egress, whereas in the fibroblasts inhibition of egress equalled the accumulation of AdoHcy. Inhibition of AdoHcy catabolism was associated with an increase in both free and protein bound L-homocysteine in liver cells, whereas depletion of intracellular L-homocysteine occurred in the mouse embryo fibroblasts under these conditions. These data suggest that some properties of nucleoside analogues may be related to their effects on L-homocysteine metabolism. Furthermore, L-homocysteine is exported into the extracellular medium in proportion to the formation from AdoHcy, and extracellular L-homocysteine may be a measure of the balance between L-homocysteine formation and utilization.
D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000032:analysis; D043383:Adenosylhomocysteinase; D000818:Animals; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism; D006710:Homocysteine / Q000031:analogs & derivatives* / Q000378:metabolism*; D006867:Hydrolases / Q000037:antagonists & inhibitors; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism*; D008715:Methionine / Q000378:metabolism; D051381:Rats; D012435:S-Adenosylhomocysteine / Q000378:metabolism*
D006710:Homocysteine; C100029:eritadenine; C034583:3-deazaaristeromycin; D000255:Adenosine Triphosphate; D012435:S-Adenosylhomocysteine; D008715:Methionine; D006867:Hydrolases; D043383:Adenosylhomocysteinase; D000225:Adenine; D000241:Adenosine